Log in

NYSE:NUS - Nu Skin Enterprises Stock Price, Forecast & News

$42.32
-0.19 (-0.45 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$42.12
Now: $42.32
$42.97
50-Day Range
$37.70
MA: $39.80
$42.56
52-Week Range
$35.03
Now: $42.32
$69.79
Volume337,398 shs
Average Volume408,692 shs
Market Capitalization$2.35 billion
P/E Ratio12.02
Dividend Yield3.48%
Beta0.77
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products. Read More…

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
CUSIP67018T10
Phone801-345-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.68 billion
Cash Flow$5.32 per share
Book Value$14.11 per share

Profitability

Net Income$121.88 million

Miscellaneous

Employees4,900
Market Cap$2.35 billion
Next Earnings Date2/12/2020 (Confirmed)
OptionableOptionable

Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.


Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Tuesday, November 5th. Shareholders of record on Friday, November 29th will be paid a dividend of $0.37 per share on Wednesday, December 11th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date of this dividend is Wednesday, November 27th. View Nu Skin Enterprises' Dividend History.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) posted its earnings results on Tuesday, November, 5th. The company reported $0.79 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.76 by $0.03. The company earned $590 million during the quarter, compared to analysts' expectations of $605.02 million. Nu Skin Enterprises had a return on equity of 23.52% and a net margin of 4.59%. The business's quarterly revenue was down 13.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.94 EPS. View Nu Skin Enterprises' Earnings History.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Nu Skin Enterprises.

How can I listen to Nu Skin Enterprises' earnings call?

Nu Skin Enterprises will be holding an earnings conference call on Wednesday, February 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its fourth quarter earnings guidance on Tuesday, November, 5th. The company provided earnings per share (EPS) guidance of $0.68-0.75 for the period, compared to the Thomson Reuters consensus estimate of $0.91. The company issued revenue guidance of $570-590 million, compared to the consensus revenue estimate of $642.26 million.

What price target have analysts set for NUS?

7 analysts have issued 1 year target prices for Nu Skin Enterprises' shares. Their forecasts range from $40.00 to $70.00. On average, they expect Nu Skin Enterprises' stock price to reach $50.29 in the next twelve months. This suggests a possible upside of 18.8% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.

What is the consensus analysts' recommendation for Nu Skin Enterprises?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nu Skin Enterprises.

What are Wall Street analysts saying about Nu Skin Enterprises stock?

Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
  • 1. According to Zacks Investment Research, "Nu Skin’s shares have underperformed the industry in the past six months. Headwinds in Mainland China, a soft view for 2020 and currency fluctuations are prime deterrents. The recently completed 100-day government campaign in Mainland China to inspect offerings of the nutrition and direct sales industry led to adversities like limited sales meetings. This took a toll on the company’s third-quarter 2019 results, with revenues and earnings declining year over year. The company also issued a soft view for the fourth quarter and 2020, wherein adverse impacts from currency movements are likely to persist. Nevertheless, the company is on track with product launches and programs to strengthen sales leaders in Mainland China. Also, the company is committed toward boosting customer base, which grew 4% in the third quarter." (11/11/2019)
  • 2. Pivotal Research analysts commented, "We suspect that NUS management has taken an axe to the outlook to avoid having to cut again." (8/7/2019)

Has Nu Skin Enterprises been receiving favorable news coverage?

Media coverage about NUS stock has been trending positive recently, according to InfoTrie. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nu Skin Enterprises earned a media sentiment score of 2.9 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Nu Skin Enterprises.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a increase in short interest in December. As of December 13th, there was short interest totalling 1,600,000 shares, an increase of 8.1% from the November 28th total of 1,480,000 shares. Based on an average trading volume of 395,800 shares, the short-interest ratio is presently 4.0 days. Approximately 3.0% of the shares of the stock are short sold. View Nu Skin Enterprises' Current Options Chain.

Who are some of Nu Skin Enterprises' key competitors?

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), Herbalife Nutrition (HLF), Marathon Petroleum (MPC), Baidu (BIDU), Alphabet (GOOG), Netflix (NFLX), Tesla (TSLA), Booking (BKNG) and Caterpillar (CAT).

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the folowing people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 66)
  • Mr. Ritch N. Wood, CEO & Director (Age 53)
  • Mr. Ryan S. Napierski, Pres (Age 45)
  • Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)
  • Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66)

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by many different of institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.02%) and FNY Investment Advisers LLC (0.00%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Edwina D Woodbury, Foulis Greg, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.

Which major investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View Insider Buying and Selling for Nu Skin Enterprises.

Which major investors are buying Nu Skin Enterprises stock?

NUS stock was bought by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC. View Insider Buying and Selling for Nu Skin Enterprises.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $42.32.

How big of a company is Nu Skin Enterprises?

Nu Skin Enterprises has a market capitalization of $2.35 billion and generates $2.68 billion in revenue each year. The company earns $121.88 million in net income (profit) each year or $3.52 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.View Additional Information About Nu Skin Enterprises.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is http://www.nuskinenterprises.com/.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]


MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  474 (Vote Outperform)
Underperform Votes:  445 (Vote Underperform)
Total Votes:  919
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel